← Back to Search

Tympanostomy Tube Device

Solo+ Tympanostomy Tube Device for Ear Infections

N/A
Waitlist Available
Research Sponsored by AventaMed DAC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Listed for bilateral tympanostomy tube insertion
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Study Summary

This trial is testing a new device for placing tympanostomy tubes in children. The goal is to see if it is safe and effective.

Who is the study for?
This trial is for children who need tubes placed in both ears to treat ear infections. They must have a clear hearing test and eardrum movement test (audiometry and tympanometry) before the study. Kids with very narrow ear canals, stiff eardrums, or certain ear shapes that make it hard to see or safely reach the eardrum aren't eligible.Check my eligibility
What is being tested?
The Solo+ Tympanostomy Tube Device is being tested for its safety and how well it works when placing grommets into kids' ears during surgery for ear infections. The device aims to improve this common procedure.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks of tympanostomy tube placement include bleeding, infection, persistent drainage from the ear, scarring of the eardrum, or issues with the tubes such as blockage or falling out.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for ear tube surgery in both ears.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Adverse Events
Successful delivery of the tympanostomy tube by the Solo+ Tympanostomy Tube Device

Trial Design

1Treatment groups
Experimental Treatment
Group I: Solo+ Tympanostomy Tube DeviceExperimental Treatment1 Intervention
The Solo+ Tympanostomy Tube Device is a disposable surgical tool designed to deliver a tympanostomy tube (grommet) into the tympanic membrane of patients undergoing a tympanostomy tube placement procedure

Find a Location

Who is running the clinical trial?

AventaMed DACLead Sponsor
3 Previous Clinical Trials
113 Total Patients Enrolled
Matija DanielStudy ChairQueen's Medical Center
3 Previous Clinical Trials
113 Total Patients Enrolled

Media Library

Solo+ Tympanostomy Tube Device (Tympanostomy Tube Device) Clinical Trial Eligibility Overview. Trial Name: NCT04148417 — N/A
Ear Infection Research Study Groups: Solo+ Tympanostomy Tube Device
Ear Infection Clinical Trial 2023: Solo+ Tympanostomy Tube Device Highlights & Side Effects. Trial Name: NCT04148417 — N/A
Solo+ Tympanostomy Tube Device (Tympanostomy Tube Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04148417 — N/A
~1 spots leftby Sep 2024